Differential induction of Ly6G and Ly6C positive myeloid derived suppressor cells in chronic kidney and liver inflammation and fibrosis

PLoS ONE

Volumn 10, Issue 3, 2015, Pages

  Höchst, Bastian ^a,b   Mikulec, Julita ^a   Baccega, Tania ^a   Metzger, Christina ^a   Welz, Meike ^a   Peusquens, Julia ^c   Tacke, Frank ^c   Knolle, Percy ^a,b   Kurts, Christian ^a   Diehl, Linda ^a,d   Ludwig Portugall, Isis ^a  

^a UNIVERSITY OF BONN   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^d UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADENINE; GAMMA INTERFERON RECEPTOR; GAMMA INTERFERON RECEPTOR BETA; LYMPHOCYTE ANTIGEN; PROTEIN LY6C; PROTEIN LY6G; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; LY ANTIGEN; LY-6C ANTIGEN, MOUSE; LY6G ANTIGEN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BILE DUCT LIGATION; CELL POPULATION; CONTROLLED STUDY; DISEASE COURSE; GENE EXPRESSION; HEPATITIS; IN VITRO STUDY; IN VIVO STUDY; KIDNEY CELL; KIDNEY FIBROSIS; LIVER CELL; LIVER FIBROSIS; MOUSE; MYELOID DERIVED SUPPRESSOR CELL; NEPHRITIS; NONHUMAN; PROTEIN EXPRESSION; SUPPRESSOR CELL; T CELL DEPLETION; ANIMAL; BONE MARROW CELL; CHRONIC KIDNEY FAILURE; GRANULOCYTE; IMMUNOLOGY; INFLAMMATION; LIVER CIRRHOSIS; METABOLISM; PHENOTYPE;

MUS;

ANIMALS; ANTIGENS, LY; BIOMARKERS; DISEASE PROGRESSION; GRANULOCYTES; INFLAMMATION; LIVER CIRRHOSIS; MICE; MYELOID CELLS; PHENOTYPE; RENAL INSUFFICIENCY, CHRONIC;

EID: 84928902651     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0119662     Document Type: Article

References (44)

1. Movahedi K, Guilliams M, Van den Bossche J, Van den Bergh R, Gysemans C, etal. Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct T cell-suppressive activity. Blood 2008. 111:4233-4244. doi: 10.1182/blood-2007-07-099226 PMID: 18272812
2. Greifenberg V, Ribechini E, Rossner S, Lutz MB. Myeloid-derived suppressor cell activation by combined LPS and IFN-gamma treatment impairs DC development. European journal of immunology 2009. 39:2865-2876. doi: 10.1002/eji.200939486 PMID: 19637228
3. Zhao X, Rong L, Zhao X, Li X, Liu X, etal. TNF signaling drives myeloid-derived suppressor cell accumulation. J Clin Invest 2012. 122:4094-4104. doi: 10.1172/JCI64115 PMID: 23064360
4. Taketo MM. Cyclooxygenase-2 inhibitors in tumorigenesis (Part II). Journal of the National Cancer Institute 1998. 90:1609-1620. PMID: 9811310
5. Taketo MM. Cyclooxygenase-2 inhibitors in tumorigenesis (part I). Journal of the National Cancer Institute 1998. 90:1529-1536. PMID: 9790545
6. Cheng P, Corzo CA, Luetteke N, Yu B, Nagaraj S, et al. Inhibition of dendritic cell differentiation and accumulation of myeloid-derived suppressor cells in cancer is regulated by S100A9 protein. The Journal of experimental medicine 2008. 205:2235-2249. doi: 10.1084/jem.20080132 PMID: 18809714
7. Foell D, Wittkowski H, Vogl T, Roth J. S100 proteins expressed in phagocytes: a novel group of damage-associated molecular pattern molecules. Journal of leukocyte biology 2007. 81:28-37. PMID: 16943388
8. Bunt SK, Sinha P, Clements VK, Leips J, Ostrand-Rosenberg S. Inflammation induces myeloid-derived suppressor cells that facilitate tumor progression. J Immunol 2006. 176:284-290. PMID: 16365420
9. Bunt SK, Yang L, Sinha P, Clements VK, Leips J, etal. Reduced inflammation in the tumor microenvironment delays the accumulation of myeloid-derived suppressor cells and limits tumor progression. Cancer research 2007. 67:10019-10026. PMID: 17942936
10. Sinha P, Clements VK, Ostrand-Rosenberg S. Reduction of myeloid-derived suppressor cells and induction of M1 macrophages facilitate the rejection of established metastatic disease. Journal of immunology 2005. 174:636-645. PMID: 15634881
11. Sinha P, Clements VK, Bunt SK, Albelda SM, Ostrand-Rosenberg S. Cross-talk between myeloidderived suppressor cells and macrophages subverts tumor immunity toward a type 2 response. Journal of immunology 2007. 179:977-983. PMID: 17617589
12. Kusmartsev S, Gabrilovich DI. Immature myeloid cells and cancer-associated immune suppression. Cancer immunology, immunotherapy 2002. 51:293-298. PMID: 12111117
13. Mazzoni A, Bronte V, Visintin A, Spitzer JH, Apolloni E, etal. Myeloid suppressor lines inhibit T cell responses by an NO-dependent mechanism. Journal of immunology 2002. 168:689-695. PMID: 11777962
14. Soehnlein O, Lindbom L. Phagocyte partnership during the onset and resolution of inflammation. Nature reviews 2010. 10:427-439. doi: 10.1038/nri2779 PMID: 20498669
15. Ostrand-Rosenberg S, Sinha P. Myeloid-derived suppressor cells: linking inflammation and cancer. Journal of immunology. 2009. 182:4499-4506. doi: 10.4049/jimmunol.0802740 PMID: 19342621
16. Youn JI, Nagaraj S, Collazo M, Gabrilovich DI. Subsets of myeloid-derived suppressor cells in tumorbearing mice. Journal of immunology 2008. 181:5791-5802. PMID: 18832739
17. Liu Y, Zeng B, Zhang Z, Zhang Y, Yang R. B7-H1 on myeloid-derived suppressor cells in immune suppression by a mouse model of ovarian cancer. Clinical immunology 2008. 129:471-481. doi: 10.1016/j.clim.2008.07.030 PMID: 18790673
18. Dietlin TA, Hofman FM, Lund BT, Gilmore W, Stohlman SA, etal. Mycobacteria-induced Gr-1+ subsets from distinct myeloid lineages have opposite effects on T cell expansion. Journal of leukocyte biology 2007. 81:1205-1212. PMID: 17307863
19. Zhu B, Bando Y, Xiao S, Yang K, Anderson AC, etal. CD11b+Ly-6C (hi) suppressive monocytes in experimental autoimmune encephalomyelitis. Journal of immunology 2007. 179:5228-5237. PMID: 17911608
20. Luan Y, Mosheir E, Menon MC, Wilson D, Woytovich C, et al. Monocytic myeloid-derived suppressor cells accumulate in renal transplant patients and mediate CD4 (+) Foxp3 (+) Treg expansion. American journal of transplantation. 13:3123-3131. doi: 10.1111/ajt.12461 PMID: 24103111
21. Rodriguez PC, Ernstoff MS, Hernandez C, Atkins M, Zabaleta J, etal. Arginase I-producing myeloidderived suppressor cells in renal cell carcinoma are a subpopulation of activated granulocytes. Cancer research 2009. 69:1553-1560. doi: 10.1158/0008-5472. CAN-08-1921 PMID: 19201693
22. Zhang H, Liu Y, Bian Z, Huang S, Han X, et al. The critical role of myeloid-derived suppressor cells and FXR activation in immune-mediated liver injury. Journal of autoimmunity. 53:55-66. doi: 10.1016/j. jaut.2014.02.010 PMID: 24721598
23. Zeng QL, Yang B, Sun HQ, Feng GH, Jin L, etal. Myeloid-derived suppressor cells are associated with viral persistence and downregulation of TCR zeta chain expression on CD8 (+) T cells in chronic hepatitis C patients. Molecules and cells. 37:66-73. doi: 10.14348/molcells.2014.2282 PMID: 24552712
24. Hoechst B, Ormandy LA, Ballmaier M, Lehner F, Kruger C, etal. A new population of myeloid-derived suppressor cells in hepatocellular carcinoma patients induces CD4 (+) CD25 (+) Foxp3 (+) T cells. Gastroenterology 2008. 135:234-243. doi: 10.1053/j.gastro.2008.03.020 PMID: 18485901
25. Hernandez-Gea V, Toffanin S, Friedman SL, Llovet JM. Role of the microenvironment in the pathogenesis and treatment of hepatocellular carcinoma. Gastroenterology. 144:512-527. doi: 10.1053/j. gastro.2013.01.002 PMID: 23313965
26. Tamura M, Aizawa R, Hori M, Ozaki H. Progressive renal dysfunction and macrophage infiltration in interstitial fibrosis in an adenine-inducedtubulointerstitial nephritis mouse model. Histochemistry and cell biology 2009. 131:483-490. doi: 10.1007/s00418-009-0557-5 PMID: 19159945
27. Huang LR, Wohlleber D, Reisinger F, Jenne CN, Cheng R., et al. Intrahepatic myeloid-cell aggregates enable local proliferation of CD8 (+) T cells and successful immunotherapy against chronic viral liver infection. Nature immunology 2013. 14:574-583. doi: 10.1038/ni.2573 PMID: 23584070
28. Teteris SA, Hochheiser K, Kurts C. Isolation of functional dendritic cells from murine kidneys for immunological characterization. Nephrology 2012. 17:364-371. doi: 10.1111/j.1440-1797.2012.01581.x PMID: 22320441
29. Gujral JS, Liu J, Farhood A, Hinson JA, Jaeschke H. Functional importance of ICAM-1 in the mechanism of neutrophil-induced liver injury in bile duct-ligated mice. American journal of physiology 2004. 286:G499-507. PMID: 14563671
30. Nefedova Y, Fishman M, Sherman S, Wang X, Beg AA, etal. Mechanism of all-trans retinoic acid effect on tumor-associated myeloid-derived suppressor cells. Cancer research 2007. 67:11021-11028. PMID: 18006848
31. Chou HS, Hsieh CC, Charles R, Wang L, Wagner T, etal. Myeloid-derived suppressor cells protect islet transplants by B7-H1 mediated enhancement of T regulatory cells. Transplantation 2012. 93:272-282. doi: 10.1097/TP.0b013e31823ffd39 PMID: 22179405
32. Song X, Krelin Y, Dvorkin T, Bjorkdahl O, Segal S, etal. CD11b+/Gr-1+ immature myeloid cells mediate suppression of T cells in mice bearing tumors of IL-1beta-secreting cells. Journal of immunology. 2005. 175:8200-8208. PMID: 16339559
33. Sinha P, Clements VK, Fulton AM, Ostrand-Rosenberg S. Prostaglandin E2 promotes tumor progression by inducing myeloid-derived suppressor cells. Cancer research 2007. 67:4507-4513. PMID: 17483367
34. Zhao X, Rong L, Zhao X, Li X, Liu X, etal. TNF signaling drives myeloid-derived suppressor cell accumulation. The Journal of clinical investigation 2012. 122:4094-4104. doi: 10.1172/JCI64115 PMID: 23064360
35. Sunderkotter C, Nikolic T, Dillon MJ, Van Rooijen N, Stehling M, etal. Subpopulations of mouse blood monocytes differ in maturation stage and inflammatory response. Journal of immunology. 2004. 172:4410-4417. PMID: 15034056
36. Voisin MB, Buzoni-Gatel D, Bout D, Velge-Roussel F. Both expansion of regulatory GR1+ CD11b+ myeloid cells and anergy of T lymphocytes participate in hyporesponsiveness of the lung-associated immune system during acute toxoplasmosis. Infection and immunity 2004. 72:5487-5492. PMID: 15322051
37. Haile LA, von Wasielewski R, Gamrekelashvili J, Kruger C, Bachmann O, et al. Myeloid-derived suppressor cells in inflammatory bowel disease: a new immunoregulatory pathway. Gastroenterology 2008. 135:871-881, 881 e871-875. doi: 10.1053/j.gastro.2008.06.032 PMID: 18674538
38. Pestka S, Kotenko SV, Muthukumaran G, Izotova LS, Cook JR, etal. The interferon gamma (IFN-gamma) receptor: a paradigm for the multichain cytokine receptor. Cytokine & growth factor reviews 1997. 8:189-206.
39. Bernabei P, Coccia EM, Rigamonti L, Bosticardo M, Forni G, etal. Interferon-gamma receptor2expression as the deciding factor in human T, B, and myeloid cell proliferation or death. Journal of leukocyte biology 2001. 70:950-960. PMID: 11739558
40. Mandruzzato S, Solito S, Falisi E, Francescato S, Chiarion-Sileni, etal. IL4Ralpha+ myeloid-derived suppressor cell expansion in cancer patients. Journal of immunology. 2009. 182:6562-6568. doi: 10.4049/jimmunol.0803831 PMID: 19414811
41. Roth F, De La Fuente AC, Vella JL, Zoso A, Inverardi L, et al. Aptamer-mediated blockade of IL4Ralpha triggers apoptosis of MDSCs and limits tumor progression. Cancer research 2012. 72:1373-1383. doi: 10.1158/0008-5472. CAN-11-2772 PMID: 22282665
42. Chou HS, Hsieh CC, Yang HR, Wang L, Arakawa Y, etal. Hepatic stellate cells regulate immune response by way of induction of myeloid suppressor cells in mice. Hepatology 2011. 53:1007-1019. doi: 10.1002/hep. 24162 PMID: 21374665
43. Hochst B, Schildberg FA, Sauerborn P, Gabel YA, Gevensleben, et al. Activated human hepatic stellate cells induce myeloid derived suppressor cells from peripheral blood monocytes in a CD44-dependent fashion. Journal of hepatology 2013. 59:528-535. doi: 10.1016/j.jhep. 2013.04.033 PMID: 23665041
44. Lauvau G, Chorro L, Spaulding E, Soudja SM. Inflammatory monocyte effector mechanisms. Cellular immunology. 2014. 291:32-40. doi: 10.1016/j.cellimm.2014.07.007 PMID: 25205002